about
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapyAdvances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in UrineCD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression.Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand.Mechanisms of oxysterol-induced carcinogenesis.Cohort profile: cholangiocarcinoma screening and care program (CASCAP).A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma.A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand.Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells.Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma.Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinomaRisk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.Protein kinases as targets for Opisthorchis viverrini- associated cholangiocarcinoma therapy.Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool.Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process.Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment.Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma.Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis.Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells.Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression.High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis.Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression.Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment.Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells.Suppression of PRKAR1A expression enhances anti-proliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma cells.Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis.Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines.Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway.Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance.Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling.Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines.Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem.Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance.Carcinogenic Liver Fluke and Others Contaminated in Pickled Fish of Northeastern Thailand
P50
Q27320588-67C104A6-6C60-4278-AA6F-2A3F9C726B3BQ28550418-C5270033-BF39-4540-AC98-D5B03DD29F36Q30378139-22A9F975-D924-49D1-850E-7A6F8EFE3A3EQ34420486-371251F5-6E56-45F4-B568-C29CB1006098Q34508893-678768F3-C135-4EC6-93C6-ABEAEA20645AQ34704784-8960C137-3AEA-46D6-A5D4-7D2795C902CAQ35693985-E7FCC77F-C7D7-4EF4-B6E8-7D2DD9868AFEQ35759806-AF0EBD77-6158-47EA-8BD4-D052ED2AEB95Q35900738-A8BBCEB4-1FF6-469E-BA82-BD1B48C5FF5AQ36887069-2156A5CE-BE55-48BE-9D4A-4874900DE59FQ37302761-EA43B514-EBFA-4044-BBC3-9D05DDDDB3E4Q37700926-2E814251-EB3F-4F40-A915-DF3740E595A6Q38177241-ECAE0668-D445-4204-89BB-E2D8A60202DFQ38682881-98D57D99-5149-4198-976B-DF2C5EBE9FB4Q38697195-B952AE99-9274-41A8-832D-51D02EFB4D1EQ38698388-A847F748-CABA-4DE5-9444-4FF0693531A0Q38710232-EDB7CB45-C094-4657-822B-584CCAFB340DQ38735435-00AD0BCA-026A-4C55-A30D-34DE3F6084BDQ38889640-2E5FBE65-5346-4302-902D-CC0076022DA8Q38899560-599CF9E8-987F-41DF-A7AC-66AB8EA768E2Q38923596-5F9CD0D9-EDFB-4996-AF7C-3D829A22A50BQ38969734-8B0A80F9-C257-47AB-88F0-5E19C65990DAQ38990922-4E0C8DA5-65D4-4274-86CD-9549C18F9A12Q38991030-DFA1D6C4-058F-4B30-864B-C6E675A5027DQ39079721-BDA32898-8345-4A0B-90F3-0305C3227C15Q39129195-B52D2909-0CB6-4A06-8682-4CDCBAC7CD2AQ39132926-CEB7F099-D7D7-40A3-8347-EE9E97722F67Q39295117-CAF97B16-E8FC-4F97-90D0-744B60F78061Q39325255-EB036451-E963-4E2B-8FE0-C49C526EBA1EQ39420341-8422B4F1-3D11-40E1-8E23-D4D345C294EAQ39420381-5D72E684-AB1C-4E54-A0D4-E7EF5A6D89E2Q39505757-CBEEF2AB-3EE6-440D-B1C1-95B1436A9A4AQ39705348-19FA9ACF-4F54-4EA8-9DE3-447E35315734Q39756253-B2C34929-E83E-4D5C-BFC9-7FD4F9BA54C7Q39796626-D5663752-4CC4-424A-8284-718D917DC07FQ39865088-CC2C1BF5-DC7F-434A-BB8E-067689CAB764Q39949063-FF6AC461-DEC1-4514-9517-FF23466A35C5Q40076769-5503CCD7-A6E4-458E-9B1E-AEDD892DB059Q40221733-BD84BD05-ED70-46EB-A038-B14844C93EB6Q40277482-2EE7C00A-FB73-4166-8E26-A2E1BE2196C0
P50
name
Watcharin Loilome
@en
type
label
Watcharin Loilome
@en
prefLabel
Watcharin Loilome
@en